J Kevin Buchi Amneal Pharmaceuticals, Inc. (AMRX) insider trading activity

AMRX Quotes by TradingView

J Kevin Buchi is Director of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 40,258 shares of AMRX, which is worth approximately $288,649. The most recent transaction as insider was on May 05, 2025, when has been sold 40,258 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.3K
Infinity% 3M change
84.64% 12M change
Total Value Held $288,649

J KEVIN BUCHI Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 05 2025
BUY
Exercise of conversion of derivative security
-
40,258 Added 50.0%
40,258 Class A Common Stock
Mar 10 2025
SELL
Bona fide gift
-
262,072 Reduced 100.0%
0 Class A Common Stock
May 10 2024
BUY
Exercise of conversion of derivative security
-
76,453 Added 22.58%
262,072 Class A Common Stock
May 10 2023
BUY
Exercise of conversion of derivative security
-
80,128 Added 30.15%
185,619 Class A Common Stock
May 08 2022
BUY
Exercise of conversion of derivative security
-
35,406 Added 25.13%
105,491 Class A Common Stock
May 06 2021
BUY
Exercise of conversion of derivative security
-
46,218 Added 39.74%
70,085 Class A Common Stock

Also insider at

AMPE
Ampio Pharmaceuticals, Inc. Healthcare
Director
BNTC
Benitec Biopharma Inc. Healthcare
Director
TCRT
Alaunos Therapeutics, Inc. Healthcare
Director
DRNA
Dicerna Pharmaceuticals Inc
Director
JKB

J Kevin Buchi

Director
Boston, MA

Track Institutional and Insider Activities on AMRX

Follow Amneal Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

News

Receive news related to Amneal Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AMRX